The factors that showed statistical differences or were close to significance among the unilateral and bilateral breast cancer patients in our series were identified as axillary nodal status, subgroup, estrogen receptor (ER) status, Her-2 expression status, axillary surgery, and chemotherapy type. This evidence concerns the gene ERBB2 and breast carcinoma.